SI1082330T1 - Platinum complex, its preparation and therapeutic application - Google Patents

Platinum complex, its preparation and therapeutic application

Info

Publication number
SI1082330T1
SI1082330T1 SI9930056T SI9930056T SI1082330T1 SI 1082330 T1 SI1082330 T1 SI 1082330T1 SI 9930056 T SI9930056 T SI 9930056T SI 9930056 T SI9930056 T SI 9930056T SI 1082330 T1 SI1082330 T1 SI 1082330T1
Authority
SI
Slovenia
Prior art keywords
preparation
platinum complex
therapeutic application
therapeutic
application
Prior art date
Application number
SI9930056T
Other languages
English (en)
Slovenian (sl)
Inventor
Frantisek Zak
Adolf Mistr
Anna Poulova
Milan Melka
Jaroslav Turanek
Dana Zaluska
Original Assignee
Pliva-Lachema A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema A.S. filed Critical Pliva-Lachema A.S.
Publication of SI1082330T1 publication Critical patent/SI1082330T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C07F15/0093—Platinum compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SI9930056T 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application SI1082330T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ19981628A CZ288912B6 (cs) 1998-05-27 1998-05-27 Komplex platiny v oxidačním čísle IV, způsob přípravy tohoto komplexu, tento komplex jako léčivo a farmaceutická kompozice tento komplex obsahující
EP99920541A EP1082330B1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application
PCT/CZ1999/000015 WO1999061451A1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application

Publications (1)

Publication Number Publication Date
SI1082330T1 true SI1082330T1 (en) 2002-08-31

Family

ID=5463562

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930056T SI1082330T1 (en) 1998-05-27 1999-05-24 Platinum complex, its preparation and therapeutic application

Country Status (24)

Country Link
US (1) US6503943B1 (cs)
EP (1) EP1082330B1 (cs)
JP (1) JP3575686B2 (cs)
CN (1) CN1124279C (cs)
AU (1) AU741380B2 (cs)
BG (1) BG64599B1 (cs)
BR (1) BR9910669B1 (cs)
CA (1) CA2332054C (cs)
CZ (1) CZ288912B6 (cs)
DE (1) DE69901177T2 (cs)
ES (1) ES2175968T3 (cs)
HR (1) HRP20000791B1 (cs)
HU (1) HU224716B1 (cs)
IL (1) IL139529A (cs)
MX (1) MXPA00011621A (cs)
NO (1) NO328930B1 (cs)
PL (1) PL191132B1 (cs)
PT (1) PT1082330E (cs)
RS (1) RS49738B (cs)
RU (1) RU2200164C2 (cs)
SI (1) SI1082330T1 (cs)
SK (1) SK284436B6 (cs)
UA (1) UA56315C2 (cs)
WO (1) WO1999061451A1 (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408805A (pt) * 2003-03-31 2006-03-28 Pliva Lachema As composição farmacêutica contendo complexo de platina e método de fabricação da mesma
CZ296045B6 (cs) * 2003-03-31 2005-12-14 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku komplex čtyřmocné platiny a způsob její výroby
CZ295584B6 (cs) * 2004-02-12 2005-08-17 Pliva-Lachema A. S. Farmaceutická kompozice obsahující jako účinnou látku platinový komplex a způsob výroby této kompozice
CA2584493A1 (en) 2004-06-18 2006-01-05 Gpc Biotech, Inc. Kinase inhibitors for treating cancers
US20080272022A1 (en) * 2004-07-14 2008-11-06 Gpc Biotech Ag Variable-Dose Packaging System
CZ296169B6 (cs) * 2004-09-08 2006-01-11 Pliva - Lachema A. S. Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
CZ2004964A3 (cs) * 2004-09-14 2006-03-15 Pliva-Lachema A. S. Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
WO2007008247A2 (en) * 2004-11-10 2007-01-18 University Of South Florida Platinum complexes for targeted drug delivery
EP1859797A4 (en) * 2005-02-28 2011-04-13 Eisai R&D Man Co Ltd NEW SIMULTANEOUS USE OF A SULPHONAMIDE COMPOUND AND A MEDIUM AGAINST CANCER
EP1792622A1 (en) 2005-11-11 2007-06-06 GPC Biotech AG Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and EGFR inhibitors or pyrimidine analogues
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
CZ300590B6 (cs) * 2006-06-20 2009-06-24 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
KR100829173B1 (ko) * 2006-09-19 2008-05-13 광주과학기술원 물에 대한 용해도가 우수한 플라틴 복합체의 포접복합체 및그 제조방법
GB2457453B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form III of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
GB2457452B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Amorphous form of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) amminedichloroplatinum (IV)
GB2457454B (en) * 2008-02-12 2010-05-12 Pliva Lachema As Polymorphic crystalline form II of (OC-6-43)-bis(acetate)(1-tricyclo[3,3,1,13,7]decylamine) ammine dichloroplatinum (IV)
GB2457455B (en) * 2008-02-12 2010-04-21 Pliva Lachema As Polymorphic crystalline form (I) of (OC-6-43)-Bis(Acetato)-1-(Tricyclo[3,3,1,1 (3,7)]Decylamine)Amminedichloroplatinum(IV)
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
US20120238488A1 (en) 2009-09-08 2012-09-20 Konstantinos Alevizopoulos Compounds and methods for treating neoplasia
WO2012013816A1 (en) 2010-07-30 2012-02-02 Medexis S.A. Compounds and methods for treating neoplasia
DK3189064T3 (en) 2014-09-03 2018-11-12 Vuab Pharma A S PLATIN (IV) complex with increased antitumor effect
CN104984356A (zh) * 2015-05-14 2015-10-21 昆明贵研药业有限公司 赛特铂的环糊精复合物及制备方法
RU2613513C2 (ru) * 2015-07-17 2017-03-16 Федеральное государственное бюджетное учреждение науки Институт проблем химической физики Российской академии наук (ИПХФ РАН) Способ получения комплексов платины (IV) с аминонитроксильными радикалами
RU2726826C2 (ru) * 2016-12-27 2020-07-15 Общество с ограниченной ответственностью "Плат-АН" (ООО "Плат-АН") Композиция на основе аминонитроксильного комплекса платины и доксорубицина и способ лечения опухолей
CN114341147B (zh) 2019-09-05 2024-05-07 韦埃博制药公司 具有显著增强的抗肿瘤功效的铂ⅳ配合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063119T3 (es) * 1988-02-02 1995-01-01 Johnson Matthey Inc Complejos de pt (iv).
FI905018A7 (fi) * 1989-10-17 1991-04-18 Bristol Myers Squibb Co Veteen ja liuottimeen liukenevat aksiaaliset hydroksi- ja mono- ja di-karboksyylihappojohdannaiset, joilla on korkea kasvainaktiivisuus
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
RU2089555C1 (ru) * 1995-05-04 1997-09-10 Новосибирский институт биоорганической химии СО РАН Бисимидазол-(1,10)-фенантролинплатина (iii) дихлорид, проявляющий цитостатическую противоопухолевую активность
JPH10265380A (ja) * 1997-03-17 1998-10-06 Bristol Myers Squibb Co 抗ガン剤

Also Published As

Publication number Publication date
EP1082330B1 (en) 2002-04-03
BR9910669A (pt) 2001-01-30
NO20005990L (no) 2000-11-27
ES2175968T3 (es) 2002-11-16
RS49738B (sr) 2008-04-04
CA2332054A1 (en) 1999-12-02
PT1082330E (pt) 2002-09-30
NO20005990D0 (no) 2000-11-27
HU224716B1 (en) 2006-01-30
JP3575686B2 (ja) 2004-10-13
SK17732000A3 (sk) 2001-05-10
MXPA00011621A (es) 2003-03-12
HUP0102549A3 (en) 2004-04-28
AU741380B2 (en) 2001-11-29
SK284436B6 (sk) 2005-04-01
CZ162898A3 (cs) 1999-12-15
HRP20000791A2 (en) 2001-02-28
IL139529A0 (en) 2001-11-25
PL191132B1 (pl) 2006-03-31
BG64599B1 (bg) 2005-08-31
RU2200164C2 (ru) 2003-03-10
JP2002516332A (ja) 2002-06-04
CN1303388A (zh) 2001-07-11
HUP0102549A2 (hu) 2001-11-28
AU3809399A (en) 1999-12-13
PL344346A1 (en) 2001-11-05
YU71900A (sh) 2002-10-18
HRP20000791B1 (en) 2006-07-31
CA2332054C (en) 2005-06-28
UA56315C2 (uk) 2003-05-15
CZ288912B6 (cs) 2001-09-12
CN1124279C (zh) 2003-10-15
EP1082330A1 (en) 2001-03-14
IL139529A (en) 2004-06-20
NO328930B1 (no) 2010-06-21
US6503943B1 (en) 2003-01-07
DE69901177D1 (de) 2002-05-08
BG104972A (en) 2001-08-31
BR9910669B1 (pt) 2011-07-26
DE69901177T2 (de) 2002-10-02
WO1999061451A1 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
PL344346A1 (en) Platinum complex, its preparation and therapeutic application
HU9900163D0 (en) Sterol and stanol-esters, preparation and use thereof
IL139286A0 (en) Polyol-ifn-beta conjugates, their preparation and use
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
PL343512A1 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
PL351250A1 (en) Antipicornaviral compounds, their preparation and use
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
IL145150A0 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
HUP0201762A3 (en) Platinum complex, its preparation and therapeutic application
HUP0104510A3 (en) Benzofuran derivatives, their preparation and use
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
IL148446A0 (en) Iren protein, its preparation and use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
GB2332671B (en) Acetals, their preparation and their use
HUP0203678A3 (en) Nitro-sulfobenzamide-derivatives, preparation and use thereof
AU3715499A (en) Citronellyl and/or dihydrocitronellyl lactates, preparation and use thereof
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
IL133242A0 (en) 5-Naphthalene-1-yl-1,3-dioxane derivatives their preparation and their therapeutic application
AU5522499A (en) 2-aminoethyl-quinoline derivatives, preparation and therapeutic use
HUP0100584A3 (en) Triazepinones, process for their preparation and their therapeutic application
HU9800542D0 (en) Epoxy-azetidinones, preparation and use thereof
IL134604A0 (en) Nap protein, its preparation and use
AU8536698A (en) Lus-1 human protein, its production and use